GEODE CAPITAL MANAGEMENT, LLC - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,603,675
-28.2%
756,352
+4.7%
0.00%
Q2 2023$2,232,231
+31.3%
722,405
+128.6%
0.00%
Q1 2023$1,699,794
+153311.0%
315,947
+89.5%
0.00%
Q4 2022$1,108
-99.8%
166,765
+23.0%
0.00%
Q3 2022$539,000
+1.1%
135,598
+26.3%
0.00%
Q2 2022$533,000
-65.7%
107,375
-58.2%
0.00%
Q1 2022$1,552,000
-46.7%
257,000
+2.5%
0.00%
Q4 2021$2,914,000
-31.6%
250,775
-7.8%
0.00%
-100.0%
Q3 2021$4,263,000
+17.4%
271,937
+39.7%
0.00%0.0%
Q2 2021$3,631,000
-55.2%
194,726
+3.5%
0.00%0.0%
Q1 2021$8,112,000188,2150.00%
Other shareholders
VOR BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,361,723$34,226,0708.75%
OUP Management Co., LLC 374,714$2,015,9614.02%
Paradigm Biocapital Advisors LP 6,477,999$34,851,6353.30%
RA Capital Management 22,748,880$122,388,9742.77%
JOHNSON & JOHNSON 1,074,658$5,781,6601.88%
Artal Group S.A. 2,792,805$15,0250.89%
Trustees of Columbia University in the City of New York 91,910$494,4760.88%
Sarissa Capital Management LP 618,000$3,324,8400.42%
Laurion Capital Management LP 3,182,889$17,123,9430.12%
Woodline Partners LP 1,111,123$5,977,8420.08%
View complete list of VOR BIOPHARMA INC shareholders